NOV 25, 2019 10:40 AM PST

eRapid: molecular diagnostic power in the palm of your hand

WRITTEN BY: Tara Fernandez

We’ve heard lofty biotech promises in the news of being able to diagnose diseases from a single drop of blood. Yet, diagnostic procedures for the majority of diseases still require lab-based techniques run by trained experts.

Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University believe their new handheld electrochemical device, called “eRapid”, is capable of performing where other attempts at portable diagnostic devices have fallen short.

eRAPID: a Platform for Portable Diagnostics from Wyss Institute on Vimeo.

In the latest issue of Nature Nanotechnology, researchers Jonathan Sabaté del Río and colleagues describe a highly sensitive and inexpensive device that uses nanomaterial-coated sensors to pick up traces of disease biomarkers in biological samples.

The problem with existing technologies, such as glucometers used to quantify glucose levels in diabetics’ blood, is that over time, biological material from the sample can start to coat the sensors, rendering them inactive.

One way to impede this process, known as “biofouling”, is to coat sensors with various antifouling materials. However, this approach has proven to be an uphill battle for manufacturers of diagnostic devices, due to issues with consistency.

To tackle this challenge, the Wyss Institute engineers used a porous matrix of negatively-charged proteins as a coating, linked to the electrochemical sensors. This nanomaterial coating acted as a filter to keep positively-charged proteins in the blood from binding to the electrodes and blocking their action.

The difference this made to eRapid’s performance was impressive. Without the coating, sensors exposed to blood samples fizzled out in their ability to conduct signals within a day. On the other hand, coated sensors retained more than 90 percent of their sensitivity despite being immersed in a blood sample for a month.

Further testing revealed eRapid was capable of detecting diagnostic biomarkers with remarkable sensitivity: sensing up to a trillionth of a gram of these molecules within a single milliliter of blood.

What does the future hold for these next-generation diagnostic devices? By stacking multiple sensors in a single device, the inventors foresee eRapid becoming a widely-used portable, low-cost platform for clinical diagnostics and environmental testing alongside other applications. According to the authors, we can expect to see this potentially life-saving technology used everywhere from emergency situations to routine home care.

 

Sources: Harvard News, Nature Nanotechnology.

 

Photo credit: Wyss Institute at Harvard University

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
SEP 14, 2019
Chemistry & Physics
SEP 14, 2019
What is Photoacoustic Imaging?
In the last decade, photoacoustic tomography has slowly emerged as a versatile, radiation-free imaging modality that bears great potentials for basic resea...
SEP 24, 2019
Immunology
SEP 24, 2019
Flu Shot Less Effective Due to Overuse of Antibioitics
New research out of the Stanford University School of Medicine shows that the consequence of overuse of antibiotics lowers the effectiveness of the seasona...
DEC 23, 2019
Clinical & Molecular DX
DEC 23, 2019
Long awaited at-home test gives hemophiliacs peace of mind
Haemophilia is a genetically-inherited condition that severely affects an individual’s ability to stop bleeding. Blood clotting is a natural protecti...
DEC 23, 2019
Technology
DEC 23, 2019
Can Artifical Intelligence Detect Leukemia?
Artificial intelligence has always been a hot topic of discussion in the medical sciences with a whirlwind of applications. However, know the latest curios...
JAN 06, 2020
Genetics & Genomics
JAN 06, 2020
Some Genetic Sequencing Tests Are Coming Up Short
If it's suspected that a person has a genetic disease, doctors might send the patient's DNA for sequencing. But some sequencing tests may not be checking thoroughly....
JAN 28, 2020
Clinical & Molecular DX
JAN 28, 2020
Protein complex discovered as first biomarker of PTSD
  Researchers at the Centre for Addiction and Mental Health (CAMH) and the Canadian Institutes of Health Research (CIHR) have identified a potential d...
Loading Comments...